Annual Current Liabilities
$740.56 M
+$371.75 M+100.80%
December 1, 2024
Summary
- As of February 25, 2025, GMAB annual total current liabilities is $740.56 million, with the most recent change of +$371.75 million (+100.80%) on December 1, 2024.
- During the last 3 years, GMAB annual current liabilities has risen by +$501.85 million (+210.24%).
- GMAB annual current liabilities is now at all-time high.
Performance
GMAB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$740.56 M
+$53.81 M+7.83%
December 1, 2024
Summary
- As of February 25, 2025, GMAB quarterly total current liabilities is $740.56 million, with the most recent change of +$53.81 million (+7.83%) on December 1, 2024.
- Over the past year, GMAB quarterly current liabilities has increased by +$53.81 million (+7.83%).
- GMAB quarterly current liabilities is now at all-time high.
Performance
GMAB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
GMAB Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.8% | +7.8% |
| 3 y3 years | +210.2% | +7.8% |
| 5 y5 years | +426.6% | +7.8% |
GMAB Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +210.2% | at high | +268.6% |
| 5 y | 5-year | at high | +426.6% | at high | +577.6% |
| alltime | all time | at high | +5729.8% | at high | +1627.6% |
Genmab A/S Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $740.56 M(+100.8%) | $740.56 M(+7.8%) |
| Sep 2024 | - | $686.75 M(+9.6%) |
| Jun 2024 | - | $626.46 M(+57.0%) |
| Mar 2024 | - | $399.10 M(+8.2%) |
| Dec 2023 | $368.80 M(+40.6%) | $368.80 M(-10.3%) |
| Sep 2023 | - | $411.01 M(+41.3%) |
| Jun 2023 | - | $290.84 M(+1.6%) |
| Mar 2023 | - | $286.18 M(+9.1%) |
| Dec 2022 | $262.38 M(+9.9%) | $262.38 M(-33.6%) |
| Sep 2022 | - | $394.93 M(+44.7%) |
| Jun 2022 | - | $272.93 M(+35.8%) |
| Mar 2022 | - | $200.93 M(-15.8%) |
| Dec 2021 | $238.71 M(+15.3%) | $238.71 M(-16.4%) |
| Sep 2021 | - | $285.50 M(+32.1%) |
| Jun 2021 | - | $216.20 M(+6.1%) |
| Mar 2021 | - | $203.80 M(-1.6%) |
| Dec 2020 | $207.10 M(+47.3%) | $207.10 M(-41.8%) |
| Sep 2020 | - | $356.03 M(+17.5%) |
| Jun 2020 | - | $303.07 M(+177.3%) |
| Mar 2020 | - | $109.29 M(-22.3%) |
| Dec 2019 | $140.63 M(+106.8%) | $140.63 M(+46.6%) |
| Sep 2019 | - | $95.95 M(+20.1%) |
| Jun 2019 | - | $79.91 M(+22.0%) |
| Mar 2019 | - | $65.48 M(-3.7%) |
| Dec 2018 | $68.02 M(+29.0%) | $68.02 M(+36.1%) |
| Sep 2018 | - | $49.96 M(-3.8%) |
| Jun 2018 | - | $51.94 M(+21.2%) |
| Mar 2018 | - | $42.87 M(-18.7%) |
| Dec 2017 | $52.72 M(-9.9%) | $52.72 M(-22.0%) |
| Sep 2017 | - | $67.55 M(-25.5%) |
| Jun 2017 | - | $90.63 M(+58.0%) |
| Mar 2017 | - | $57.37 M(-2.0%) |
| Dec 2016 | $58.53 M | $58.53 M(-7.2%) |
| Sep 2016 | - | $63.05 M(+11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $56.55 M(-4.2%) |
| Mar 2016 | - | $59.06 M(-2.7%) |
| Dec 2015 | $60.70 M(-43.3%) | $60.70 M(-12.6%) |
| Sep 2015 | - | $69.47 M(-9.9%) |
| Jun 2015 | - | $77.08 M(-9.2%) |
| Mar 2015 | - | $84.90 M(-20.7%) |
| Dec 2014 | $107.10 M(-36.2%) | $107.10 M(-12.7%) |
| Sep 2014 | - | $122.63 M(-15.7%) |
| Jun 2014 | - | $145.54 M(-8.3%) |
| Mar 2014 | - | $158.64 M(-5.6%) |
| Dec 2013 | $167.97 M(-19.9%) | $167.97 M(-20.0%) |
| Sep 2013 | - | $210.03 M(+13.8%) |
| Jun 2013 | - | $184.62 M(-6.1%) |
| Mar 2013 | - | $196.52 M(-6.3%) |
| Dec 2012 | $209.79 M(+23.3%) | $209.79 M(-8.7%) |
| Sep 2012 | - | $229.75 M(+48.0%) |
| Jun 2012 | - | $155.27 M(-7.3%) |
| Mar 2012 | - | $167.42 M(-1.6%) |
| Dec 2011 | $170.20 M(-28.0%) | $170.20 M(-13.2%) |
| Sep 2011 | - | $196.03 M(-8.8%) |
| Jun 2011 | - | $214.85 M(-3.4%) |
| Mar 2011 | - | $222.38 M(-5.9%) |
| Dec 2010 | $236.30 M(+36.8%) | $236.30 M(+1.4%) |
| Sep 2010 | - | $232.92 M(+100.5%) |
| Jun 2010 | - | $116.20 M(-23.8%) |
| Mar 2010 | - | $152.53 M(-11.7%) |
| Dec 2009 | $172.79 M(-12.9%) | $172.79 M |
| Dec 2008 | $198.30 M(-5.0%) | - |
| Dec 2007 | $208.73 M(+535.2%) | - |
| Dec 2006 | $32.86 M(-12.7%) | - |
| Dec 2005 | $37.62 M(+195.4%) | - |
| Dec 2004 | $12.74 M(+0.3%) | - |
| Dec 2003 | $12.70 M(-43.9%) | - |
| Dec 2002 | $22.64 M | - |
FAQ
- What is Genmab A/S annual total current liabilities?
- What is the all time high annual current liabilities for Genmab A/S?
- What is Genmab A/S annual current liabilities year-on-year change?
- What is Genmab A/S quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Genmab A/S?
- What is Genmab A/S quarterly current liabilities year-on-year change?
What is Genmab A/S annual total current liabilities?
The current annual current liabilities of GMAB is $740.56 M
What is the all time high annual current liabilities for Genmab A/S?
Genmab A/S all-time high annual total current liabilities is $740.56 M
What is Genmab A/S annual current liabilities year-on-year change?
Over the past year, GMAB annual total current liabilities has changed by +$371.75 M (+100.80%)
What is Genmab A/S quarterly total current liabilities?
The current quarterly current liabilities of GMAB is $740.56 M
What is the all time high quarterly current liabilities for Genmab A/S?
Genmab A/S all-time high quarterly total current liabilities is $740.56 M
What is Genmab A/S quarterly current liabilities year-on-year change?
Over the past year, GMAB quarterly total current liabilities has changed by +$53.81 M (+7.83%)